NRGene Technologies Ltd
Tel Aviv Stock Exchange NRGN.TA
NRGene Technologies Ltd Price to Earnings Ratio (P/E) on January 14, 2025: -2.28
NRGene Technologies Ltd Price to Earnings Ratio (P/E) is -2.28 on January 14, 2025, a -43.03% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
-
NRGene Technologies Ltd 52-week high Price to Earnings Ratio (P/E) is -1.52 on January 17, 2024, which is 33.38% above the current Price to Earnings Ratio (P/E).
-
NRGene Technologies Ltd 52-week low Price to Earnings Ratio (P/E) is -6.08 on December 20, 2024, which is -166.42% below the current Price to Earnings Ratio (P/E).
-
NRGene Technologies Ltd average Price to Earnings Ratio (P/E) for the last 52 weeks is -2.42.
Key data
| Date | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: NRGN.TA
| CEO | Dr. Gil Ronen Ph.D. |
| IPO Date | Jan. 31, 2021 |
| Location | Israel |
| Headquarters | Golda Meir Street |
| Employees | 50 |
| Sector | Health Care |
| Industries | |
Description
NRGene Technologies Ltd, an AI genomics company, provides computational tools and develops advanced algorithms in North America, Europe, Middle East, Africa, Asia Pacific, and internationally. It offers software tools; and turnkey solutions to breeding agricultural and food technology companies, academia, research institutes, and agribiotech companies. The company also develops custom panels for various plants including wheat, canola, corn, soybean, maize, etc., as well as cannabis. NRGene Technologies Ltd was incorporated in 2009 and is based in Ness Ziona, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email